PLSE

PULSE BIOSCIENCES, INC. PLSE

NasdaqMid CapHealthcare

13F Pro quality score

Rank #2,823 of 2,925

Why it scores 15Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$434.0K

Quarter to Jun 30

Net income

$-24.66M

Quarter to Jun 30

Free cash flow

$-18.80M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$296.39M total
BlackRock, Inc.
$40.67M+9.5%
BANK OF AMERICA CORP /DE/
$40.11M+67.0%
VANGUARD CAPITAL MANAGEMENT LLC
$21.87M-3.3%
Portolan Capital Management, LLC
$20.89M+2.7%
PRICE T ROWE ASSOCIATES INC /MD/
$20.76M+4938.3%
BALYASNY ASSET MANAGEMENT L.P.
$19.91M+170.8%
CITADEL ADVISORS LLC
$17.37M+340.7%
GEODE CAPITAL MANAGEMENT, LLC
$14.87M+9.0%
STATE STREET CORP
$14.69M+15.9%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
$12.83M0.0%
UBS Group AG
$7.64M+711.9%
GRIFFIN ASSET MANAGEMENT, INC.
$6.30M+0.9%
VANGUARD PORTFOLIO MANAGEMENT LLC
$4.98M+8.7%
NORTHERN TRUST CORP
$4.81M-7.3%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$4.21M+2.9%
VANGUARD FIDUCIARY TRUST CO
$3.64M+0.5%
Point72 Asset Management, L.P.
$2.95MNew
NORGES BANK
$2.93M--
Nuveen, LLC
$2.82M+123.8%
Panoramic Capital, LLC
$2.72M+68.9%
D. E. Shaw & Co., Inc.
$2.27M+496.1%
Westside Investment Management, Inc.
$2.16M+10.3%
WELLINGTON MANAGEMENT GROUP LLP
$2.07M-8.0%
SECTORAL ASSET MANAGEMENT INC
$1.88MNew
Bank of New York Mellon Corp
$1.20M+12.1%
See all 106 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/PLSE

Earnings Per Share

13fpro.ai/company/PLSE

Loading ratio trend…

PLSE insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About PULSE BIOSCIENCES, INC. (PLSE): stock profile, AI score and financials

PULSE BIOSCIENCES, INC. (PLSE) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PLSE at 14.5/100 on a composite quality score built from its SEC filings, placing it at rank #2,823 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), PULSE BIOSCIENCES, INC. reports quarterly revenue of $434.0K, net income of $-24.7M, free cash flow of $-18.8M. PLSE trades on the Nasdaq exchange and files with the SEC under CIK 1625101. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PLSE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for PULSE BIOSCIENCES, INC. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1625101 →